Discovery of Novel Pleuromutilin Derivatives as Potent Antibacterial Agents for the Treatment of MRSA Infection

Discovery of Novel Pleuromutilin Derivatives as Potent Antibacterial Agents for the Treatment of MRSA Infection

A series of novel pleuromutilin derivatives containing nitrogen groups on the side chain of C14 were synthesized under mild conditions. Most of the synthesized derivatives displayed potent antibacterial activities. Compound <b>9</b> was found to be the most active antibacterial derivativ...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Han-Qing Fang, Jie Zeng, Shou-Kai Wang, Xiao Wang, Fang Chen, Bo Li, Jie Liu, Zhen Jin, Ya-Hong Liu, You-Zhi Tang
Natura:	Articolo
Lingua:	English
Pubblicazione:	MDPI AG 2022-01-01
Serie:	Molecules
Soggetti:	antibacterial activity MRSA pleuromutilin SPR 50S ribosome
Accesso online:	https://www.mdpi.com/1420-3049/27/3/931

Documenti analoghi

Design, synthesis, biological evaluation and molecular docking study of novel pleuromutilin derivatives containing substituted benzoxazole as antibacterial agents
di: Jie Ren, et al.
Pubblicazione: (2023-12-01)

Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups
di: Qi Wang, et al.
Pubblicazione: (2022-12-01)

Synthesis and Biological Evaluation of New Pleuromutilin Derivatives as Antibacterial Agents
di: Ruo-Feng Shang, et al.
Pubblicazione: (2014-11-01)

Antibacterial Activity and Pharmacokinetic Profile of a Promising Antibacterial Agent: 22-(2-Amino-phenylsulfanyl)-22-Deoxypleuromutilin
di: Xiangyi Zuo, et al.
Pubblicazione: (2020-02-01)

Assessing Boron-Pleuromutilin AN11251 for the Development of Antibacterial Agents
di: Ming-Jie Han, et al.
Pubblicazione: (2023-06-01)

Synthesis, biological activities and docking studies of pleuromutilin derivatives with piperazinyl urea linkage
di: Yuanyuan Zhang, et al.
Pubblicazione: (2021-01-01)

In Vitro and In Vivo Antibacterial Activity, Toxicity and Resistance Analysis of Pleuromutilin Derivative Z33 against Methicillin-Resistant <i>Staphylococcus aureus</i>
di: Yuhan Hu, et al.
Pubblicazione: (2022-08-01)

Antibacterial Activity of a Promising Antibacterial Agent: 22-(4-(2-(4-Nitrophenyl-piperazin-1-yl)-acetyl)-piperazin-1-yl)-22-deoxypleuromutilin
di: Xiang-Yi Zuo, et al.
Pubblicazione: (2021-06-01)

Synthesis, testing, and computational modeling of pleuromutilin 1,2,3-triazole derivatives in the ribosome
di: Logan M. Breiner, et al.
Pubblicazione: (2022-12-01)

Synthesis and Antibacterial Activity of Alkylamine-Linked Pleuromutilin Derivatives
di: Kerrin Hainsworth, et al.
Pubblicazione: (2024-10-01)

Preliminary SAR of Novel Pleuromutilin–Polyamine Conjugates
di: Kenneth Sue, et al.
Pubblicazione: (2023-11-01)

Design, Synthesis and Biological Evaluation of Novel Pleuromutilin Derivatives Containing 6-Chloro-1-R-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine-4-amino Side Chain
di: Jun Wang, et al.
Pubblicazione: (2023-05-01)

In-Silico Design and Evaluation of the Anti-Wolbachia Potential of Boron-Pleuromutilins
di: Fabian Audu Ugbe, et al.
Pubblicazione: (2023-05-01)

Insights into the Classical Genetics of Clitopilus passeckerianus – the Pleuromutilin Producing Mushroom
di: Kate M. J. de Mattos-Shipley, et al.
Pubblicazione: (2017-06-01)

Pharmacokinetic/pharmacodynamic integration of amphenmulin: a novel pleuromutilin derivative against Mycoplasma gallisepticum
di: Wenxiang Wang, et al.
Pubblicazione: (2024-02-01)

Synergistic Effect of Pleuromutilins with Other Antimicrobial Agents against Staphylococcus aureus In Vitro and in an Experimental Galleria mellonella Model
di: Chun-Liu Dong, et al.
Pubblicazione: (2017-08-01)

Molecular Docking Screening and Pharmacokinetic Studies of Some Boron-Pleuromutilin Analogues against Possible Targets of Wolbachia pipientis
di: Fabian Audu Ugbe, et al.
Pubblicazione: (2022-10-01)

Cprp—An Unusual, Repetitive Protein Which Impacts Pleuromutilin Biosynthesis in the Basidiomycete Clitopilus passeckerianus
di: Kate M. J. de Mattos-Shipley, et al.
Pubblicazione: (2021-04-01)

The Very First Modification of Pleuromutilin and Lefamulin by Photoinitiated Radical Addition Reactions—Synthesis and Antibacterial Studies
di: Son Thai Le, et al.
Pubblicazione: (2021-11-01)

Assessment of the Risk to Public Health due to Use of Antimicrobials in Pigs—An Example of Pleuromutilins in Denmark
di: Lis Alban, et al.
Pubblicazione: (2017-05-01)

Identification of a New Antimicrobial Resistance Gene Provides Fresh Insights Into Pleuromutilin Resistance in Brachyspira hyodysenteriae, Aetiological Agent of Swine Dysentery
di: Roderick M. Card, et al.
Pubblicazione: (2018-06-01)

Determination of In Vitro Antimicrobial Susceptibility for Lefamulin (Pleuromutilin) for <i>Ureaplasma</i> Spp. and <i>Mycoplasma hominis</i>
di: Oliver Spiller-Boulter, et al.
Pubblicazione: (2021-11-01)

Discovery of Brominated Alboflavusins With Anti-MRSA Activities
di: Chao Li, et al.
Pubblicazione: (2021-02-01)

Design and Synthesis of Anti-MRSA Benzimidazolylbenzene-sulfonamides. QSAR Studies for Prediction of Antibacterial Activity
di: Fidel Martínez-Gutiérrez, et al.
Pubblicazione: (2010-12-01)

Antibacterial Effect of Zataria multiflora Extract on MRSA
di: Maryam Motevasel, et al.
Pubblicazione: (2014-11-01)

Potentiation activity of multiple antibacterial agents by Salvianolate from the Chinese medicine Danshen against methicillin-resistant Staphylococcus aureus (MRSA)
di: Qing-Qing Liu, et al.
Pubblicazione: (2016-05-01)

A Comprehensive Overview of the Antibiotics Approved in the Last Two Decades: Retrospects and Prospects
di: Zhenfeng Shi, et al.
Pubblicazione: (2023-02-01)

Antibacterial activity of recently approved antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) strains: A systematic review and meta-analysis
di: Fei Liu, et al.
Pubblicazione: (2022-08-01)

Potency of xanthone derivatives as antibacterial agent against Methicillin-Resistant Staphylococcus Aureus (MRSA)
di: Isnatin Miladiyah, et al.
Pubblicazione: (2017-06-01)

IN VITRO ANTIBACTERIAL ACTIVITY OF EUCALYPTUS (Melaleuca leucadendra) OIL AGAINST METHICILLIN-RESISTANT Staphylococcus aureus (MRSA)
di: Constantia Lidwina Targanski, et al.
Pubblicazione: (2023-07-01)

A Novel Ivermectin-Derived Compound D4 and Its Antimicrobial/Biofilm Properties against MRSA
di: Xinyi Tan, et al.
Pubblicazione: (2021-02-01)

Determination of Tiamulin Concentration in Sow Milk and in Sera of Suckling Piglets
di: Piotr Cybulski, et al.
Pubblicazione: (2023-10-01)

Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities
di: Thomas M. File, et al.
Pubblicazione: (2021-05-01)

Discovery of Furanoquinone Derivatives as a Novel Class of DNA Polymerase and Gyrase Inhibitors for MRSA Eradication in Cutaneous Infection
di: Shih-Chun Yang, et al.
Pubblicazione: (2019-05-01)

Purification and Characterization of Novel Anti-MRSA Peptides Produced by <i>Brevibacillus</i> sp. SPR-20
di: Nuttapon Songnaka, et al.
Pubblicazione: (2022-12-01)

Bacteria-Targeted Clindamycin Loaded Polymeric Nanoparticles: Effect of Surface Charge on Nanoparticle Adhesion to MRSA, Antibacterial Activity, and Wound Healing
di: Nurhasni Hasan, et al.
Pubblicazione: (2019-05-01)

Synthesis and Inhibitory Activity of Machaeridiol-Based Novel Anti-MRSA and Anti-VRE Compounds and Their Profiling for Cancer-Related Signaling Pathways
di: Mallika Kumarihamy, et al.
Pubblicazione: (2022-10-01)

Discovery of N-quinazolinone-4-hydroxy-2-quinolone-3-carboxamides as DNA gyrase B-targeted antibacterial agents
di: Wenjie Xue, et al.
Pubblicazione: (2022-12-01)

Anti-MRSA malleable liposomes carrying chloramphenicol for ameliorating hair follicle targeting
di: Hsu C, et al.
Pubblicazione: (2017-11-01)

Antibacterial effects of green laser in vicinity of silver nanoparticles on methicillin-resistant staphylococcus aureus (MRSA)
di: Maliheh Ranjbaran, et al.
Pubblicazione: (2021-07-01)